Full metabolic adjustment typically takes 3 to 6 months
10.1016/j.taap.2004.10.018 Toxicol
doi: 10.1016/j.molmet.2019.09.010 102
Current research status indicates that BPC-157 is under investigation in clinical trial NCT02637284, designated as PCO-02, which focuses on safety and pharmacokinetic evaluation
JAMA Intern Med 173:534539 Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC (2011) Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
These setbacks demonstrate that while GLP-1 RAs show promising biomarker effects in the brain, translating them into meaningful clinical outcomes in neurodegeneration remains an unresolved challenge